Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
BriaCell Therapeutics Corp | BCT | Toronto | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
9.56 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 5.32 - 15.05 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 9.56 | CAD |
BriaCell Therapeutics Corp Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 148.35M | 13.38M | 13.38M | $ - | $ 0.00 | -2.22 | 696.80 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
92.24k | $ - | - | 52.53k | - |
BriaCell Therapeutics News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BCT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 9.63 | 9.75 | 9.10 | 9.46 | 5,069 | -0.07 | -0.73% |
1 Month | 9.68 | 10.68 | 8.50 | 9.42 | 13,237 | -0.12 | -1.24% |
3 Months | 6.07 | 10.81 | 5.94 | 9.22 | 12,022 | 3.49 | 57.5% |
6 Months | 7.84 | 10.81 | 5.77 | 8.62 | 9,168 | 1.72 | 21.94% |
1 Year | 12.05 | 15.05 | 5.32 | 8.97 | 9,186 | -2.49 | -20.66% |
3 Years | 10.84 | 15.05 | 5.32 | 9.08 | 8,728 | -1.28 | -11.81% |
5 Years | 10.84 | 15.05 | 5.32 | 9.08 | 8,728 | -1.28 | -11.81% |
BriaCell Therapeutics Description
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer. |